Development of next-generation anticoagulant therapy using nutri-pharmaogenomic approach
Project/Area Number |
25460661
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Applied pharmacology
|
Research Institution | Kanazawa Medical University |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | ファーマコゲノミクス / 血栓 / 抗凝固薬 / 脂質代謝 / ビタミンK / ファーマコゲノミックス |
Outline of Final Research Achievements |
Intestinal cholesterol transporter NPC1L1-genotype dependent influence of dietary vit K intake on warfarin anticoagulation was examined in 232 patients. Only in those with VKORC1 -1639A/G heterozygotes, NPC1L1 functional SNP rs2072813 influenced significantly on the relation between warfarin efficiency and the amount of vit K intake, suggesting possible role of NPC1L1 linking lipid metabolism and thrombogenic diseases. In subjects receiving novel anticoagulant, Xa inhibitor, Xa activity and several biomarkers were measured in 50 patients. F1+2 showed the best association with Xa activity among examined variables, and Xa activity in addition to sex, age, body weight, and creatinine was independent determinant for F1+2 level.
|
Report
(4 results)
Research Products
(11 results)
-
-
-
[Journal Article] Clinical characteristics of patients with Rutherford category IV, compared with V and VI.2015
Author(s)
Tsuchiya T, Iida O, Shiraki T, Soga Y, Hirano K, Suzuki K, Yamaoka T, Miyashita Y, Kitayama M, Kajinami K.
-
Journal Title
SAGE Open Med.
Volume: 3
Pages: 7087-7087
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.2014
Author(s)
Saito R, Takeda K, Yamamoto K, Nakagawa A, Aoki H, Fujibayashi K, Wakasa M, Motoyama A, Iwadare M, Ishida R, Fujioka N, Tsuchiya T, Akao H, Kawai Y, Kitayama M, Kajinami K.
-
Journal Title
J Thromb Thrombolysis.
Volume: 38
Issue: 1
Pages: 105-114
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm.2014
Author(s)
Tanabe K, Kawai Y, Kitayama M, Akao H, Ishida R, Motoyama A, Wakasa M, Saito R, Aoki H, Fujibayashi K, Watanabe M, Tsuchiya T, Kimura H, Yoshida K, Kajinami K.
-
Journal Title
Journal of Cardiology
Volume: 印刷中
Issue: 2
Pages: 86-90
DOI
Related Report
Peer Reviewed
-
[Journal Article] ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment2014
Author(s)
Akao H, Polisecki1 E, Schaefer EJ, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJM, Packard C, Buckley BM, Kajinami K.
-
Journal Title
Atherosclerosis
Volume: 235
Issue: 1
Pages: 176-181
DOI
Related Report
Peer Reviewed
-
[Journal Article] ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.2014
Author(s)
Akao H, Polisecki1 E, Schaefer EJ, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJM, Packard C, Buckley BM, Kajinami K.
-
Journal Title
Atherosclerosis
Volume: -
Related Report
Peer Reviewed
-
-
[Journal Article] Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry.2013
Author(s)
Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T; PACIFIC investigators.
-
Journal Title
Circ J.
Volume: 77
Pages: 934-943
Related Report
Peer Reviewed
-
[Presentation] Prothrombin activation fragment (F1+2) as an index of anticoagulant therapy with factor Xa inhibitor in atrial fibrillation2016
Author(s)
Ueno E, Fujibayashi K, Sawaguchi J, Yasuda Y, Takano S, Saito R, Wakasa M, Fujioka N, Kawai Y, Kajinami K.
Organizer
ESC congress 2016
Place of Presentation
Rome, Italy
Year and Date
2016-08-27
Related Report
Int'l Joint Research
-
[Presentation] Nutri-pharmacogenomic interaction of intestinal cholesterol transporter (NPC1L1) with VKORC1 as a determinant of warfarin anticoagulation2016
Author(s)
Saito R, Takeda K, Aoki H, Fujibayashi K, Wakasa M, Motoyama A, Fujioka N, Akao H, Kawai Y, Tsuchiya T, Kitayama M, Kajinami K.
Organizer
第80回日本循環器学会学術集会
Place of Presentation
仙台国際会議場(宮城県仙台市)
Year and Date
2016-03-18
Related Report